- Biogen Inc revealed surprise plans to seek U.S. regulatory approval for its Alzheimer’s treatment aducanumab on Tuesday, saying new analysis of clinical trials showed promise, just months after it had shelved two studies.
Biogen and partner Eisai Co Ltd had in March decided to end two late-stage trials of aducanumab based on a so-called “futility analysis” of data, which revealed the trials had little hope of succeeding. The company said more data became available after the two studies that were discontinued in March, resulting in a larger dataset and a new analysis showed a positive outcome for the trial.
“The viability of such a filing is unknown, given the mixed results - in our view, Biogen is somewhat desperate for growth drivers...so a change in narrative is badly needed.”
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Stocks making the biggest moves premarket: Biogen, Under Armour, P&G, Hasbro & moreThese are the stocks posting the largest moves before the bell.
Source: CNBC - 🏆 12. / 72 Read more »
Stocks making the biggest moves premarket: Biogen, Under Armour, P&G, Hasbro & moreThese are the stocks posting the largest moves before the bell.
Source: CNBC - 🏆 12. / 72 Read more »
Procter & Gamble earnings, sales top estimates, shares jumpProcter & Gamble has been enjoying strong sales, driven in part by innovation, marketing and speed to market. Last quarter, organic sales grew by 7%. Why is Ylan Mui chasing Mark Zuckerberg down the halls of Congress pelting him with him unanswered questions like he’s some kind of child murderer? You don’t do it to anyone else, you should stop it
Source: CNBC - 🏆 12. / 72 Read more »
Teva, three U.S. drug distributors reach opioid settlement - sourceDrug maker Teva Pharmaceutical Industries Inc and the three biggest U.S. drug di... Where's my money!
Source: Reuters - 🏆 2. / 97 Read more »
RS Charts: YoungBoy Never Broke Again Tops Artists 500 Chart.GGYOUNGBOY takes the throne on this week’s Artists 500 chart after seeing massive first-week streams for 'AI Youngboy 2' GGYOUNGBOY Who?
Source: RollingStone - 🏆 483. / 51 Read more »